HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vicki L Keedy Selected Research

Giant Cell Tumor of Tendon Sheath

4/2022Turalio risk evaluation and mitigation strategy for treatment of tenosynovial giant cell tumor: framework and experience.
1/2016Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
7/2015Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vicki L Keedy Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 12/2007
9Sarcoma (Soft Tissue Sarcoma)
01/2022 - 01/2012
4Neoplasm Metastasis (Metastasis)
03/2019 - 12/2007
3Giant Cell Tumor of Tendon Sheath
04/2022 - 07/2015
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2022 - 02/2016
3Fibroma (Fibromatosis)
12/2012 - 09/2012
3Aggressive Fibromatosis (Desmoid)
12/2012 - 09/2012
2Carcinoma (Carcinomatosis)
01/2022 - 08/2009
2Synovial Sarcoma (Synovioma)
01/2022 - 08/2018
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 02/2015
2Chordoma
02/2016 - 04/2010
2Giant Cell Tumors (Giant Cell Tumor)
07/2015 - 10/2012
2Lung Neoplasms (Lung Cancer)
01/2013 - 05/2008
2Cicatrix (Scar)
12/2012 - 10/2012
2Leiomyosarcoma
11/2009 - 08/2009
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2009 - 12/2007
1Edema (Dropsy)
04/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Nausea
01/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Myxoid Liposarcoma
01/2022
1Liposarcoma
11/2020
1Brain Neoplasms (Brain Tumor)
03/2019
1Neurofibrosarcoma (MPNST)
03/2019
1Melanoma (Melanoma, Malignant)
05/2018
1Febrile Neutropenia
11/2016
1Dermatofibrosarcoma
02/2016
1Alveolar Soft Part Sarcoma
02/2016
1Pain (Aches)
01/2016
1Inflammation (Inflammations)
01/2016
1Body Weight (Weight, Body)
01/2015
1Clinical Deterioration
06/2014
1Disease Progression
03/2013
1Osteoblastoma
10/2012
1Osteosarcoma (Osteogenic Sarcoma)
10/2012

Drug/Important Bio-Agent (IBA)

3pexidartinibIBA
04/2022 - 07/2015
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022 - 04/2010
3Macrophage Colony-Stimulating FactorIBA
01/2022 - 07/2015
3Phosphotransferases (Kinase)IBA
11/2020 - 10/2012
3Pharmaceutical PreparationsIBA
05/2018 - 03/2013
3Irinotecan (Camptosar)FDA LinkGeneric
01/2015 - 11/2012
2Tyrosine Kinase InhibitorsIBA
01/2022 - 02/2016
2Estrogen ReceptorsIBA
01/2022 - 12/2012
2ErbB Receptors (EGF Receptor)IBA
12/2021 - 10/2012
2pazopanibFDA Link
11/2020 - 02/2016
2vactosertibIBA
01/2020 - 01/2020
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 12/2012
2Biological ProductsIBA
01/2013 - 11/2009
2Protein Isoforms (Isoforms)IBA
10/2012 - 04/2010
2Proteins (Proteins, Gene)FDA Link
10/2012 - 04/2010
2EnzymesIBA
04/2010 - 08/2009
1tyramine-deoxysorbitolIBA
04/2022
1B7-H1 AntigenIBA
01/2022
1atezolizumabIBA
01/2022
1Nuclear Proteins (Protein, Nuclear)IBA
01/2022
1molibresibIBA
01/2022
1fms-Like Tyrosine Kinase 3IBA
01/2022
1seribantumabIBA
12/2021
1Monoclonal AntibodiesIBA
12/2021
1olaparibIBA
11/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2021
1regorafenibIBA
11/2020
1Transforming Growth Factor-beta Type I ReceptorIBA
01/2020
11- (3- (1- methyl- 1H- pyrazol- 4- yl)- 5- oxo- 5H- benzo(4,5)cyclohepta(1,2- b)pyridin- 7- yl)- N- (pyridin- 2- ylmethyl)methanesulfonamideIBA
10/2018
1Docetaxel (Taxotere)FDA Link
08/2018
1GemcitabineFDA Link
08/2018
1Immune Checkpoint InhibitorsIBA
05/2018
1isophosphamide mustard (IPAM)IBA
11/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2016
1cediranib (AZD2171)IBA
02/2016
1Imatinib Mesylate (Gleevec)FDA Link
02/2016
1Sunitinib (Sutent)FDA Link
02/2016
1Sorafenib (BAY 43-9006)FDA Link
02/2016
1PlatinumIBA
02/2015
1Carboplatin (JM8)FDA LinkGeneric
02/2015
1Albumin-Bound PaclitaxelFDA Link
02/2015
1Etoposide (VP 16)FDA LinkGeneric
02/2015
1Androgen Receptors (Androgen Receptor)IBA
12/2012
1Estrogens (Estrogen)FDA Link
12/2012
1Steroid Receptors (Steroid Receptor)IBA
12/2012
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
12/2012
1CateninsIBA
12/2012
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
12/2012
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2012
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2012
1Proto-Oncogene Proteins c-metIBA
10/2012
1Mitogen-Activated Protein KinasesIBA
10/2012

Therapy/Procedure

14Therapeutics
01/2022 - 09/2006
9Drug Therapy (Chemotherapy)
08/2018 - 09/2006
3Radiotherapy
03/2019 - 11/2009
1Castration
01/2022
1Duration of Therapy
01/2022
1Drug Tapering
01/2022
1Particle Accelerators
03/2019
1Aftercare (After-Treatment)
03/2019
1Immunotherapy
05/2018
1Cell- and Tissue-Based Therapy (Cell Therapy)
05/2018
1Molecular Targeted Therapy
12/2012